Compare PBH & ATRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PBH | ATRO |
|---|---|---|
| Founded | 1996 | 1968 |
| Country | United States | United States |
| Employees | N/A | 2620 |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.7B |
| IPO Year | 2004 | N/A |
| Metric | PBH | ATRO |
|---|---|---|
| Price | $62.00 | $67.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $80.75 | ★ $86.00 |
| AVG Volume (30 Days) | 358.7K | ★ 535.1K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2.88 | N/A |
| EPS | ★ 2.78 | N/A |
| Revenue | ★ $975,777,000.00 | N/A |
| Revenue This Year | N/A | $14.99 |
| Revenue Next Year | $2.15 | $8.44 |
| P/E Ratio | $23.33 | ★ N/A |
| Revenue Growth | ★ 36.77 | N/A |
| 52 Week Low | $57.25 | $19.90 |
| 52 Week High | $88.55 | $83.96 |
| Indicator | PBH | ATRO |
|---|---|---|
| Relative Strength Index (RSI) | 30.65 | 36.41 |
| Support Level | $60.75 | $44.36 |
| Resistance Level | $63.26 | $82.37 |
| Average True Range (ATR) | 1.81 | 4.85 |
| MACD | -0.82 | -1.42 |
| Stochastic Oscillator | 0.11 | 12.56 |
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.